Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-12

Clinical Trial Update: Resperine, Gabapentin, or Lamotrigine for the Treatment of Cocaine Dependence: 2 - 7 [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating resperine, gabapentin, or lamotrigine for cocaine-related disorders; the Phase 2 study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)
  • Lamotrigine (lamotrigine)
  • Resperine (reserpine)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cocaine-Related Disorders | Phase 2 | Status: COMPLETED